Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro (vol 9, 6078, 2019)

被引:0
|
作者
Chen, Suxiang [1 ,2 ]
Le, Bao T. [1 ,2 ]
Chakravarthy, Madhuri [1 ,2 ]
Kosbar, Tamer R. [1 ]
Veedu, Rakesh N. [1 ,2 ]
机构
[1] Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Murdoch, WA 6150, Australia
[2] Perron Inst Neurol & Translat Sci, Perth, WA 6150, Australia
关键词
D O I
10.1038/s41598-020-63706-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
引用
收藏
页数:1
相关论文
共 34 条
  • [21] Evaluation of 2′-Deoxy-2′-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy
    Jirka, Silvana M. G.
    Tanganyika-de Winter, Christa L.
    Boertje-van der Meulen, Joke W.
    van Putten, Maaike
    Hiller, Monika
    Vermue, Rick
    de Visser, Peter C.
    Aartsma-Rus, Annemieke
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2015, 4 : e265
  • [22] Antisense Oligonucleotide-Mediated Exon Skipping Restores Primary Cilia Assembly in Fibroblasts Harbouring the Common Leber Congenital Amaurosis CEP290 Mutation
    Gerard, Xavier
    Perrault, Isabelle
    Hanein, Sylvain
    Silva, Eduardo
    Bigot, Karine
    Delhemmes, Sabine Defoort
    Rio, Marlene
    Munnich, Arnold
    Scherman, Daniel
    Kaplan, Josseline
    Kichler, Antoine
    Rozet, Jean-Michel
    MOLECULAR THERAPY, 2012, 20 : S166 - S167
  • [23] Evaluation of exon skipping activity of 2′-deoxy-2′-fluoro antisense oligonucleotides for Duchenne muscular dystrophy
    Jirka, S. M. G.
    van der Meulen, J. W.
    Tanganyika-de Winter, C. L.
    van Putten, M.
    Hiller, M.
    Vermue, R.
    de Visser, P. C.
    Aartsma-Rus, A.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 827 - 828
  • [24] Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP)
    Yilmaz-Elis, A. Seda
    Aartsma-Rus, Annemieke
    't Hoen, Peter A. C.
    Safdar, Huma
    Breukel, Cor
    van Vlijmen, Bart J. M.
    van Deutekom, Judith
    de Kimpe, Sjef
    van Ommen, Gert-Jan
    Verbeek, J. Sjef
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2013, 2 : e66
  • [25] Antisense oligonucleotide-mediated TRA2β poison exon inclusion induces the expression of a lncRNA with anti-tumor effects
    Leclair, Nathan K.
    Brugiolo, Mattia
    Park, Sunghee
    Devoucoux, Maeva
    Urbanski, Laura
    Angarola, Brittany L.
    Yurieva, Marina
    Anczukow, Olga
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [26] Intramuscular Evaluation of Chimeric Locked Nucleic Acid/2′OMethyl-Modified Antisense Oligonucleotides for Targeted Exon 23 Skipping in Mdx Mice
    Georgiadou, Michaella
    Christou, Melina
    Sokratous, Kleitos
    Wengel, Jesper
    Michailidou, Kyriaki
    Kyriacou, Kyriacos
    Koutsoulidou, Andrie
    Mastroyiannopoulos, Nikolaos P.
    Phylactou, Leonidas A.
    PHARMACEUTICALS, 2021, 14 (11)
  • [27] Antisense-Oligonucleotide Mediated Exon Skipping in Activin-Receptor-Like Kinase 2: Inhibiting the Receptor That Is Overactive in Fibrodysplasia Ossificans Progressiva
    Shi, SongTing
    Cai, Jie
    de Gorter, David J. J.
    Sanchez-Duffhues, Gonzalo
    Kemaladewi, Dwi U.
    Hoogaars, Willem M. H.
    Aartsma-Rus, Annemieke
    't Hoen, Peter A. C.
    ten Dijke, Peter
    PLOS ONE, 2013, 8 (07):
  • [28] Nucleobase-modified antisense oligonucleotides containing 5-(phenyltriazol)-2′-deoxyuridine nucleotides induce exon-skipping in vitro
    Le, Bao T.
    Hornum, Mick
    Sharma, Pawan K.
    Nielsen, Poul
    Veedu, Rakesh N.
    RSC ADVANCES, 2017, 7 (86): : 54542 - 54545
  • [29] A novel human muscle cell model of Duchenne muscular dystrophy created by CRISPR/Cas9 and evaluation of antisense-mediated exon skipping
    Shimo, Takenori
    Hosoki, Kana
    Nakatsuji, Yusuke
    Yokota, Toshifumi
    Obika, Satoshi
    JOURNAL OF HUMAN GENETICS, 2018, 63 (03) : 365 - 375
  • [30] A novel human muscle cell model of Duchenne muscular dystrophy created by CRISPR/Cas9 and evaluation of antisense-mediated exon skipping
    Takenori Shimo
    Kana Hosoki
    Yusuke Nakatsuji
    Toshifumi Yokota
    Satoshi Obika
    Journal of Human Genetics, 2018, 63 : 365 - 375